BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12488407)

  • 21. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.
    Baxter NN; Durham SB; Phillips KA; Habermann EB; Virning BA
    J Am Geriatr Soc; 2009 Mar; 57(3):403-11. PubMed ID: 19278395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer.
    Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
    J Geriatr Oncol; 2019 Sep; 10(5):705-708. PubMed ID: 30795923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer.
    Hassett MJ; O'Malley AJ; Pakes JR; Newhouse JP; Earle CC
    J Natl Cancer Inst; 2006 Aug; 98(16):1108-17. PubMed ID: 16912263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort.
    Du XL; Lairson DR; Begley CE; Fang S
    J Clin Oncol; 2005 Dec; 23(34):8620-8. PubMed ID: 16314624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Unplanned Hospitalizations in Patients With Nonmetastatic Lung Cancer During Chemotherapy.
    Fessele KL; Hayat MJ; Atkins RL
    Oncol Nurs Forum; 2017 Sep; 44(5):E203-E212. PubMed ID: 28820513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.
    Ji J; Bae M; Sun CL; Wildes TM; Freedman RA; Magnuson A; O'Connor T; Moy B; Klepin HD; Chapman AE; Tew WP; Dotan E; Fenton MA; Kim H; Katheria V; Gross CP; Cohen HJ; Muss HB; Sedrak MS
    Cancer; 2024 Mar; 130(6):936-946. PubMed ID: 37962093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
    Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
    JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer.
    Raji MA; Tamborello LP; Kuo YF; Ju H; Freeman JL; Zhang DD; Giordano SH; Goodwin JS
    Med Oncol; 2009 Dec; 26(4):452-9. PubMed ID: 19067255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors Associated With Unplanned Hospitalizations Among Patients With Nonmetastatic Colorectal Cancers Intended for Treatment in the Ambulatory Setting.
    Fessele KL; Hayat MJ; Mayer DK; Atkins RL
    Nurs Res; 2016; 65(1):24-34. PubMed ID: 26657478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term mortality in older patients treated with adjuvant chemotherapy for early-stage breast cancer.
    Rosenstock AS; Lei X; Tripathy D; Hortobagyi GN; Giordano SH; Chavez-MacGregor M
    Breast Cancer Res Treat; 2016 Jun; 157(2):339-350. PubMed ID: 27146586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of emergency hospitalisation and survival outcomes following adjuvant chemotherapy for early breast cancer in New South Wales, Australia.
    Tervonen HE; Chen TYT; Lin E; Boyle FM; Moylan EJ; Della-Fiorentina SA; Beith J; Johnston A; Currow DC
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13125. PubMed ID: 31222826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer.
    Srokowski TP; Fang S; Hortobagyi GN; Giordano SH
    J Clin Oncol; 2009 May; 27(13):2170-6. PubMed ID: 19307509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Information gained from linking SEER Cancer Registry Data to state-level hospital discharge abstracts. Surveillance, Epidemiology, and End Results.
    Brooks JM; Chrischilles E; Scott S; Ritho J; Chen-Hardee S
    Med Care; 2000 Nov; 38(11):1131-40. PubMed ID: 11078053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment for breast cancer in patients with Alzheimer's disease.
    Gorin SS; Heck JE; Albert S; Hershman D
    J Am Geriatr Soc; 2005 Nov; 53(11):1897-904. PubMed ID: 16274370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study.
    Chavez-MacGregor M; Zhao H; Fang S; Srokowski TP; Hortobagyi GN; Giordano SH
    Cancer; 2011 Aug; 117(16):3641-9. PubMed ID: 21656514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women.
    Lairson DR; Parikh RC; Cormier JN; Chan W; Du XL
    Value Health; 2015 Dec; 18(8):1070-8. PubMed ID: 26686793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results.
    Du X; Freeman JL; Goodwin JS
    J Clin Epidemiol; 1999 May; 52(5):463-70. PubMed ID: 10360342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.
    Rosenstock AS; Niu J; Giordano SH; Zhao H; Wolff AC; Chavez-MacGregor M
    Cancer; 2018 Mar; 124(5):899-906. PubMed ID: 29236294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in end-of-life care and health care spending in women with uterine cancer.
    Margolis B; Chen L; Accordino MK; Clarke Hillyer G; Hou JY; Tergas AI; Burke WM; Neugut AI; Ananth CV; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2017 Oct; 217(4):434.e1-434.e10. PubMed ID: 28709581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.